https://www.selleckchem.com/pr....oducts/trastuzumab-d
The RVEF/PASP ratio showed a significant correlation with RVLS. RVAC had a stronger correlation with the RVEF/PASP ratio than other indices. Multivariate Cox proportional-hazard analysis identified a lower 3D RVEF and worse RVLS as strong predictors of adverse clinical events. RVAC, TPR, and PAC had varying degrees of predictive value, with optimal cutoff values of 0.74, 11.64, and 1.18, respectively. Conclusions Precapillary-PH with RV-PA uncoupling as expressed by a RVEF/PASP ratio less then 0.44 was associated with adv